nach oben

Osteoporosis International

Erschienen in:

01.04.2016 | Review Article

Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis

verfasst von: X. Wang, S. Yan, C. Liu, Y. Xu, L. Wan, Y. Wang, W. Gao, S. Meng, Y. Liu, R. Liu, D. Xu

Erschienen in: Osteoporosis International | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Previous studies suggested possible bone loss and fracture risk in patients with systemic lupus erythematosus (SLE). The aim of this systematic review and meta-analysis was to assess the strength of the relationship of SLE with fracture risk and the mean difference of bone mineral density (BMD) levels between SLE patients and controls. Literature search was undertaken in multiple indexing databases on September 26, 2015. Studies on the relationship of SLE with fracture risk and the mean difference of BMD levels between SLE patients and controls were included. Data were combined using standard methods of meta-analysis. Twenty-one studies were finally included into the meta-analysis, including 15 studies on the mean difference of BMD levels between SLE patients and controls, and 6 studies were on fracture risk associated with SLE. The meta-analysis showed that SLE patients had significantly lower BMD levels than controls in the whole body (weighted mean difference [WMD] = −0.04; 95 % CI −0.06 to −0.02; P < 0.001), femoral neck (WMD = −0.06; 95 % CI −0.07 to −0.04; P < 0.001), lumbar spine (WMD = −0.06; 95 % CI −0.09 to −0.03; P < 0.001), and total hip (WMD = −0.05; 95 % CI −0.06 to −0.03; P < 0.001). In addition, the meta-analysis also showed that SLE was significantly associated with increased fracture risk of all sites (relative risk [RR] = 1.97, 95 % CI 1.20–3.25; P = 0.008). Subgroup analysis by adjustment showed that SLE was significantly associated with increased fracture risk of all sites before and after adjusting for confounding factors (unadjusted RR = 2.07, 95 % CI 1.46–2.94, P < 0.001; adjusted RR = 1.22, 95 % CI 1.05–1.42, P = 0.01). Subgroup analysis by types of fracture showed that SLE was significantly associated with increased risks of hip fracture (RR = 1.99, 95 % CI 1.55–2.57; P < 0.001), osteoporotic fracture (RR = 1.36, 95 % CI 1.21–1.53; P < 0.001), and vertebral fracture (RR = 2.97, 95 % CI 1.71–5.16; P < 0.001). This systematic review and meta-analysis provides strong evidence for the relationship of SLE with bone loss and fracture risk.

Panopalis P, Yazdany J (2009) Bone health in systemic lupus erythematosus. Curr Rheumatol Rep 11(3):177–184CrossRefPubMed

Mohan C, Putterman C (2015) Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis. Nat Rev Nephrol 11(6):329–341CrossRefPubMed

Lisnevskaia L, Murphy G, Isenberg D (2014) Systemic lupus erythematosus. Lancet 384(9957):1878–1888CrossRefPubMed

Leffler J, Bengtsson AA, Blom AM (2014) The complement system in systemic lupus erythematosus: an update. Ann Rheum Dis 73(9):1601–1606CrossRefPubMed

Merrill JT, Buyon JP, Utset T (2014) A 2014 update on the management of patients with systemic lupus erythematosus. Semin Arthritis Rheum 44(2):e1–e2CrossRefPubMed

Wallace DJ (2015) The evolution of drug discovery in systemic lupus erythematosus. Nat Rev Rheumatol 11(10):616–620CrossRefPubMed

Lupsa BC, Insogna K (2015) Bone health and osteoporosis. Endocrinol Metab Clin N Am 44(3):517–530CrossRef

Drake MT, Clarke BL, Lewiecki EM (2015) The pathophysiology and treatment of osteoporosis. Clin Ther 37(8):1837–1850CrossRefPubMed

Reid IR (2015) Short-term and long-term effects of osteoporosis therapies. Nat Rev Endocrinol 11(7):418–428CrossRefPubMed

10.

Golob AL, Laya MB (2015) Osteoporosis: screening, prevention, and management. Med Clin N Am 99(3):587–606CrossRefPubMed

11.

Bultink IE, Harvey NC, Lalmohamed A, Cooper C, Lems WF, van Staa TP, de Vries F (2014) Elevated risk of clinical fractures and associated risk factors in patients with systemic lupus erythematosus versus matched controls: a population-based study in the United Kingdom. Osteoporos Int 25(4):1275–1283CrossRefPubMed

12.

Tang XL, Qin L, Kwok AW, Zhu TY, Kun EW, Hung VW, Griffith JF, Leung PC, Li EK, Tam LS (2013) Alterations of bone geometry, density, microarchitecture, and biomechanical properties in systemic lupus erythematosus on long-term glucocorticoid: a case-control study using HR-pQCT. Osteoporos Int 24(6):1817–1826CrossRefPubMed

13.

Furukawa M, Kiyohara C, Horiuchi T, Tsukamoto H, Mitoma H, Kimoto Y, Uchino A, Nakagawa M, Oryoji K, Shimoda T et al (2013) Prevalence and risk factors of vertebral fracture in female Japanese patients with systemic lupus erythematosus. Mod Rheumatol 23(4):765–773CrossRefPubMed

14.

Bultink IE (2012) Osteoporosis and fractures in systemic lupus erythematosus. Arthritis Care Res 64(1):2–8CrossRef

15.

Ajeganova S, Gustafsson T, Jogestrand T, Frostegard J, Hafstrom I (2015) Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study. Arthritis Res Ther 17(84)

16.

Tang XL, Griffith JF, Qin L, Hung VW, Kwok AW, Zhu TY, Kun EW, Leung PC, Li EK, Tam LS (2013) SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus 22(11):1162–1168CrossRefPubMed

17.

Casella CB, Seguro LP, Takayama L, Medeiros D, Bonfa E, Pereira RM (2012) Juvenile onset systemic lupus erythematosus: a possible role for vitamin D in disease status and bone health. Lupus 21(12):1335–1342CrossRefPubMed

18.

Mok CC, Ying SK, To CH, Ma KM (2008) Bone mineral density and body composition in men with systemic lupus erythematosus: a case control study. Bone 43(2):327–331CrossRefPubMed

19.

Borba VZ, Matos PG, da Silva Viana PR, Fernandes A, Sato EI, Lazaretti-Castro M (2005) High prevalence of vertebral deformity in premenopausal systemic lupus erythematosus patients. Lupus 14(7):529–533CrossRefPubMed

20.

Formiga F, Nolla JM, Mitjavila F, Bonnin R, Navarro MA, Moga I (1996) Bone mineral density and hormonal status in men with systemic lupus erythematosus. Lupus 5(6):623–626CrossRefPubMed

21.

Bonfa AC, Seguro LP, Caparbo V, Bonfa E, Pereira RM (2015) RANKL and OPG gene polymorphisms: associations with vertebral fractures and bone mineral density in premenopausal systemic lupus erythematosus. Osteoporos Int 26(5):1563–1571CrossRefPubMed

22.

Liyanage A, Lekamwasam S, Dissanayake SP, Munidasa D (2013) Factors that determine body composition of female systemic lupus erythematosus (SLE) patients in Sri Lanka: a comparative study using dual-energy x-ray absorptiometry. Lupus 22(9):972–976CrossRefPubMed

23.

Alele JD, Kamen DL, Hunt KJ, Ramsey-Goldman R (2011) Bone geometry profiles in women with and without SLE. J Bone Miner Res 26(11):2719–2726CrossRefPubMedPubMedCentral

24.

Wang SH, Chang YS, Liu CJ, Lai CC, Chen WS, Chen TJ, Wang SJ (2013) Association of systemic lupus erythematosus with a higher risk of cervical but not trochanteric hip fracture: a nationwide population-based study. Arthritis Care Res 65(10):1674–1681

25.

Ekblom-Kullberg S, Kautiainen H, Alha P, Leirisalo-Repo M, Julkunen H (2013) Frequency of and risk factors for symptomatic bone fractures in patients with systemic lupus erythematosus. Scand J Rheumatol 42(5):390–393CrossRefPubMed

26.

Hippisley-Cox J, Coupland C (2012) Derivation and validation of updated QFracture algorithm to predict risk of osteoporotic fracture in primary care in the United Kingdom: prospective open cohort study. BMJ 344, e3427CrossRefPubMed

27.

Weiss RJ, Wick MC, Ackermann PW, Montgomery SM (2010) Increased fracture risk in patients with rheumatic disorders and other inflammatory diseases—a case-control study with 53,108 patients with fracture. J Rheumatol 37(11):2247–2250CrossRefPubMed

28.

Mendoza-Pinto C, Garcia-Carrasco M, Sandoval-Cruz H, Munoz-Guarneros M, Escarcega RO, Jimenez-Hernandez M, Munguia-Realpozo P, Sandoval-Cruz M, Deleze-Hinojosa M, Lopez-Colombo A et al (2009) Risk factors of vertebral fractures in women with systemic lupus erythematosus. Clin Rheumatol 28(5):579–585CrossRefPubMed

29.

Li EK, Tam LS, Griffith JF, Zhu TY, Li TK, Li M, Wong KC, Chan M, Lam CW, Chu FS et al (2009) High prevalence of asymptomatic vertebral fractures in Chinese women with systemic lupus erythematosus. J Rheumatol 36(8):1646–1652CrossRefPubMed

30.

Yee CS, Crabtree N, Skan J, Amft N, Bowman S, Situnayake D, Gordon C (2005) Prevalence and predictors of fragility fractures in systemic lupus erythematosus. Ann Rheum Dis 64(1):111–113CrossRefPubMedPubMedCentral

31.

Stang A (2010) Critical evaluation of the Newcastle-Ottawa Scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25(9):603–605CrossRefPubMed

32.

Higgins JPT, Green S (2011) Cochrane Handbook for Systematic Reviews of Interventions. In: Higgins JP, Green S (eds). The Cochrane Collaboration

33.

Cochran WG (1954) The combination of estimates from different experiments. Biometrics 10(1):101–129CrossRef

34.

Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327(7414):557–560CrossRefPubMedPubMedCentral

35.

Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22(4):719–748PubMed

36.

DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7(3):177–188CrossRefPubMed

37.

Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315(7109):629–634CrossRefPubMedPubMedCentral

38.

Trapani S, Civinini R, Ermini M, Paci E, Falcini F (1998) Osteoporosis in juvenile systemic lupus erythematosus: a longitudinal study on the effect of steroids on bone mineral density. Rheumatol Int 18(2):45–49CrossRefPubMed

39.

Teichmann J, Lange U, Stracke H, Federlin K, Bretzel RG (1999) Bone metabolism and bone mineral density of systemic lupus erythematosus at the time of diagnosis. Rheumatol Int 18(4):137–140CrossRefPubMed

40.

Mak A, Lim JQ, Liu Y, Cheak AA, Ho RC (2013) Significantly higher estimated 10-year probability of fracture in lupus patients with bone mineral density comparable to that of healthy individuals. Rheumatol Int 33(2):299–307CrossRefPubMed

41.

Hansen S, Gudex C, Ahrberg F, Brixen K, Voss A (2014) Bone geometry, volumetric bone mineral density, microarchitecture and estimated bone strength in Caucasian females with systemic lupus erythematosus. A cross-sectional study using HR-pQCT. Calcif Tissue Int 95(6):530–539CrossRefPubMed

42.

Abdwani R, Abdulla E, Yaroubi S, Bererhi H, Al-Zakwani I (2015) Bone mineral density in juvenile onset systemic lupus erythematosus. Indian Pediatr 52(1):38–40CrossRefPubMed

43.

Rhew EY, Lee C, Eksarko P, Dyer AR, Tily H, Spies S, Pope RM, Ramsey-Goldman R (2008) Homocysteine, bone mineral density, and fracture risk over 2 years of followup in women with and without systemic lupus erythematosus. J Rheumatol 35(2):230–236PubMed

44.

Schmajuk G, Yelin E, Chakravarty E, Nelson LM, Panopolis P, Yazdany J (2010) Osteoporosis screening, prevention, and treatment in systemic lupus erythematosus: application of the systemic lupus erythematosus quality indicators. Arthritis Care Res 62(7):993–1001CrossRef

45.

Garcia-Carrasco M, Mendoza-Pinto C, Escarcega RO, Jimenez-Hernandez M, Etchegaray Morales I, Munguia Realpozo P, Rebollo-Vazquez J, Soto-Vega E, Deleze M, Cervera R (2009) Osteoporosis in patients with systemic lupus erythematosus. Isr Med Assoc J 11(8):486–491PubMed

46.

Pineau CA, Urowitz MB, Fortin PJ, Ibanez D, Gladman DD (2004) Osteoporosis in systemic lupus erythematosus: factors associated with referral for bone mineral density studies, prevalence of osteoporosis and factors associated with reduced bone density. Lupus 13(6):436–441CrossRefPubMed

47.

Becker A, Fischer R, Scherbaum WA, Schneider M (2001) Osteoporosis screening in systemic lupus erythematosus: impact of disease duration and organ damage. Lupus 10(11):809–814CrossRefPubMed

48.

Straub RH, Cutolo M, Pacifici R (2015) Evolutionary medicine and bone loss in chronic inflammatory diseases—A theory of inflammation-related osteopenia. Semin Arthritis Rheum 45(2):220–228CrossRefPubMedPubMedCentral

49.

von Scheven E, Corbin KJ, Stagi S, Cimaz R (2014) Glucocorticoid-associated osteoporosis in chronic inflammatory diseases: epidemiology, mechanisms, diagnosis, and treatment. Curr Osteoporos Rep 12(3):289–299CrossRef

50.

Sundstrom J, Arima H, Woodward M, Jackson R, Karmali K, Lloyd-Jones D, Baigent C, Emberson J, Rahimi K, MacMahon S et al (2014) Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet 384(9943):591–598CrossRef

Titel: Fracture risk and bone mineral density levels in patients with systemic lupus erythematosus: a systematic review and meta-analysis
verfasst von: X. Wang
S. Yan
C. Liu
Y. Xu
L. Wan
Y. Wang
W. Gao
S. Meng
Y. Liu
R. Liu
D. Xu
Publikationsdatum: 01.04.2016
Verlag: Springer London
Erschienen in: Osteoporosis International / Ausgabe 4/2016
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-015-3449-7

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Arthroskopie kann Knieprothese nicht hinauszögern

25.04.2024 Gonarthrose Nachrichten

Ein arthroskopischer Eingriff bei Kniearthrose macht im Hinblick darauf, ob und wann ein Gelenkersatz fällig wird, offenbar keinen Unterschied.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2016

Interleukin-35 upregulates OPG and inhibits RANKL in mice with collagen-induced arthritis and fibroblast-like synoviocytes

Effects of zoledronic acid on bone fusion in osteoporotic patients after lumbar fusion

Proton pump inhibitors and fracture: they impair bone quality and increase fall risk?

Dietary magnesium intake, bone mineral density and risk of fracture: a systematic review and meta-analysis

Left–right differences in the proximal femur’s strength of post-menopausal women: a multicentric finite element study